Lanza et al. described COVID-19 as the possible effect of RAS impairment since an imbalance between the ACE/Ang II/AT1R and ACE2/Ang-(1-7)/MasR axes results in multi-organ dysfunction and an uncontrolled inflammatory response [46]. The gene discussed is AGTR1; the disease is COVID-19.